Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study
BMC Pediatrics 2013, 13:38 doi:10.1186/1471-2431-13-38
The electronic version of this article is the complete one and can be found online at:http://www.biomedcentral.com/1471-2431/13/38
| Received: | 18 October 2012 |
| Accepted: | 19 March 2013 |
| Published: | 23 March 2013 |
© 2013 Kuo et al.; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background
The risk of allergic diseases among Kawasaki disease (KD) patients relative to the general population is not known. The aim of this study was to perform a population-based cohort study to investigate the risk of allergic diseases among children after KD in Taiwan- a country with the third highest incidence of KD in the world.
Methods
Data were obtained from the Taiwan National Health Insurance Research Database. In total, 253 patients who were 5 years of age or younger and had a first-time hospitalization with a diagnosis of KD between 1997 and 2005 were included as the study cohort and 1,012 non-KD patients matched for age and sex were included as comparison cohort. Multivariate Cox proportional hazard regression model was used to adjust for confounding and to compare the 6-year allergic-free survival rate between these two cohorts.
Results
The incidence rate of allergic diseases (184.66 per 1000 person-year) was significantly higher in the KD cohort than in the control cohort (124.99 per 1000 person-years). After adjusting for potential confounders, the adjusted hazard ratios of asthma and allergic rhinitis were 1.51 (95% confidence interval = 1.17-1.95) and 1.30 (95% confidence interval = 1.04-1.62), respectively.
Conclusion
We conclude that KD patients were at an increased risk for allergic diseases compared with the comparison cohort.
No comments:
Post a Comment